Efficacy and Safety of a Purified Standardised Bee Venom Preparation

The trial is performed to assess efficacy and safety of a purified standardised bee venom preparation in bee venom allergy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bee Venom Allergy Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Venom Hypersensitivity

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Allergopharma GmbH & Co. KG

Reinbek, 21465, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

History of bee venom allergy,
Positive RAST for bee venom,
Positive skin prick test for bee venom

Exclusion criteria

Serious chronic diseases

Treatment and study plan

bee venom

Biological

Sponsors and collaborators

Lead sponsor

Allergopharma GmbH & Co. KG

Industry

Registry information

Official study title

Immunotherapy of Bee Venom Allergy: Evaluation of a New Purified Bee Venom Preparation in Comparison With Already Published Studies.

Important dates

Study start: 2003
Primary completion: 2005
Study completion: 2010
First posted: Dec 12, 2005
Registry last updated: Mar 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed